HCV: Highlighs from EASL 2013
This activity was developed by gastroenterologists and hepatologists and other healthcare providers managing patients with heptatitis C
Learning Objectives
- Identify the most important baseline characteristics to consider when assessing benefit/risk for each individual patient in order to make best decision to treat or wait;
- Identify the next way of treatment regimens likely to be approved and understand in which patient subtypes they have been studied;
- Discuss the treatment regimens likely to be approved in the near/midterm and describe the patient populations for which these regimens are likely to be approved